These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 9501687)

  • 21. Some aspects of the management of hypertension II. Special considerations.
    Rowe WS
    Med J Aust; 1975 Mar; 1(10):307-8. PubMed ID: 1128344
    [No Abstract]   [Full Text] [Related]  

  • 22. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antihypertensive therapy in patients with 4 and 5 stage chronic kidney disease undergoing periodic dialysis].
    Goicoechea MA
    Nefrologia; 2004; 24 Suppl(6):161-71, 187-235. PubMed ID: 15696905
    [No Abstract]   [Full Text] [Related]  

  • 24. [Impact of antihypertensive treatment on target organs].
    Fregoso Padilla J
    Arch Cardiol Mex; 2002; 72 Suppl 1():S58-63. PubMed ID: 12001872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapy of arterial hypertension].
    Di Perri T
    Clin Ter; 1974 Sep; 70(5):409-24. PubMed ID: 4423620
    [No Abstract]   [Full Text] [Related]  

  • 26. Mechanisms of target organ damage caused by hypertension: therapeutic potential.
    Cohuet G; Struijker-Boudier H
    Pharmacol Ther; 2006 Jul; 111(1):81-98. PubMed ID: 16288809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertension in end-stage renal disease: target values, methods of measurement and drug therapy.
    Zoccali C
    J Nephrol; 2002; 15(2):199-201. PubMed ID: 12018640
    [No Abstract]   [Full Text] [Related]  

  • 28. Progression of renal disease: renoprotective specificity of renin-angiotensin system blockade.
    Griffin KA; Bidani AK
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1054-65. PubMed ID: 17699327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How much must blood pressure be reduced in order to obtain the remission of chronic renal disease?
    Pisoni R; Remuzzi G
    J Nephrol; 2000; 13(3):228-31. PubMed ID: 10928301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antihypertensive treatment in the elderly].
    Maki K
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():342-7. PubMed ID: 16983771
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hypertension and 24-hours blood pressure monitoring in kidney diseases].
    Csiky B; Wittmann I; Nagy J
    Orv Hetil; 2004 Feb; 145(7):323-6. PubMed ID: 15049046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Arterial hypertension in patients with nephroptosis].
    Kurbangaleev SM; Almazov VA; Maslova NP; Protasov AA; Kotenko AD
    Sov Med; 1975 Jul; (7):26-31. PubMed ID: 1216045
    [No Abstract]   [Full Text] [Related]  

  • 33. [The kidneys and hypertension].
    Hausberg M; Mann J; Kühn K
    Dtsch Med Wochenschr; 2008 Sep; 133(37):1853-6. PubMed ID: 18770487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Is the treatment of arterial hypertension a nephroprotector? Effects may be different based on the class of anti-hypertensive agents used].
    Chauveau D; Martinez F
    Rev Prat; 1993 Jan; 43(2):187-91. PubMed ID: 8502937
    [No Abstract]   [Full Text] [Related]  

  • 35. [Renal hypertension in urological patients].
    Gütgemann A; Vahlensieck W; Albrecht D
    Dtsch Med J; 1968 Apr; 19(8):286-91. PubMed ID: 5728723
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hypertension and changes in renal function].
    Chanard J
    Rev Prat; 1993 Dec; 43(20 Suppl):22-6. PubMed ID: 8146579
    [No Abstract]   [Full Text] [Related]  

  • 37. Pathologic basis and treatment considerations in chronic kidney disease-related hypertension.
    Sica D; Carl D
    Semin Nephrol; 2005 Jul; 25(4):246-51. PubMed ID: 16202697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The relationship between the gene polymorphism of TGF-beta1 and early renal injury in patients with essential hypertension, and the effect of the gene polymorphism of TGF- beta1 on the individual treatment with valsartan].
    Zhao C; Wang YY; Xiao ZX; Wang YP; Zhang QY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):428-31. PubMed ID: 17680535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Vascular impact of anti-hypertensive treatment and renal protection].
    Mogensen CE
    Curr Med Res Opin; 2005; 21 Suppl 5():S23-8. PubMed ID: 16197649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertension in human renal disease.
    Brown MA; Whitworth JA
    J Hypertens; 1992 Aug; 10(8):701-12. PubMed ID: 1325500
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.